|
SMC1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30519999999879E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69282999999965E-05 |
| Normal-vs-Stage2 |
9.821700E-02 |
| Normal-vs-Stage3 |
1.562820E-01 |
| Normal-vs-Stage4 |
6.409100E-04 |
| Stage1-vs-Stage2 |
3.902000E-01 |
| Stage1-vs-Stage3 |
1.525210E-01 |
| Stage1-vs-Stage4 |
5.117200E-01 |
| Stage2-vs-Stage3 |
7.595200E-01 |
| Stage2-vs-Stage4 |
2.694000E-01 |
| Stage3-vs-Stage4 |
1.803560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.04550000000503E-05 |
| Normal-vs-AfricanAmerican |
2.603700E-04 |
| Normal-vs-Asian |
2.382200E-01 |
| Caucasian-vs-AfricanAmerican |
8.985200E-01 |
| Caucasian-vs-Asian |
9.357600E-01 |
| AfricanAmerican-vs-Asian |
9.672600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.98030003295946E-09 |
| Normal-vs-Female |
6.111400E-01 |
| Male-vs-Female |
4.00569999947642E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.355400E-03 |
| Normal-vs-Extreme_Weight |
2.67829999955893E-07 |
| Normal-vs-Obese |
1.140030E-02 |
| Normal-vs-Extreme_Obese |
4.992600E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.001200E-01 |
| Normal_Weight-vs-Obese |
4.225800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.680000E-01 |
| Extreme_Weight-vs-Obese |
1.706310E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.293000E-01 |
| Obese-vs-Extreme_Obese |
9.314300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.856800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.162000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.22739999947252E-07 |
| Normal-vs-Age(81-100Yrs) |
8.574600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.519400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.544220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.559800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.618060E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.315000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.574600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.75639999997224E-06 |
| Normal-VS-Type2 PRCC |
1.040700E-03 |
| Normal-VS-KIRP CIMP |
8.755800E-01 |
| Normal-VS-Unclassified PRCC |
1.684000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.445200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.466050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.593600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.680170E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.269600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.612400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.94819999999441E-05 |
| Normal-vs-N1 |
2.745600E-01 |
| Normal-vs-N2 |
2.798600E-01 |
| N0-vs-N1 |
1.043370E-01 |
| N0-vs-N2 |
4.619400E-01 |
| N1-vs-N2 |
9.129600E-01 |
|
|
